Search clinical trials for: ZR202a-CoV

Total 4602 results

Stemirna Therapeutics

Recruiting

New Generation mRNA Booster Vaccine Against Emerging VOCs

Efficacy | Safety | Immunogenicity

Lao People's Democratic Republic
Instituto Grifols, S.A.

Completed

A Study to Evaluate Safety and Efficacy of Convalescent Methylene Blue Treated (MBT) Plasma From Donors Recovered From Coronavirus Disease 2019 (COVID-19)

COVID-19

Spain
Andalusian Network for Design and Translation of...

Completed

Clinical Trial to Evaluate the Efficacy of Treatment With Hyperimmune Plasma Obtained From Convalescent Antibodies of COVID-19 Infection

SARS-CoV 2

Spain
Pontificia Universidad Catolica de Chile

Completed

Immune Response to Third Dose of COVID-19 Vaccine in Solid Organ Transplant

COVID-19 | SARS-CoV-2 Infection | Solid Organ Transplant | Vaccine Response Impaired

Chile
Zhongshan People's Hospital, Guangdong, China

Recruiting

Xerostomia-optimised IMRT Versus Standard IMRT in NPC

Nasopharyngeal Carcinoma ,Xerostomia,Radiotherapy

China
Leiden University Medical Center
Merck Sharp & Dohme LLC

Completed

Effect of Neuromuscular Block and Arterial PCO2 on Surgical Rating Scale (SRS), Following Reversal With Sugammadex (BLISSS2)

Prostate Cancer | Renal Cancer

Netherlands
Jiangsu Province Centers for Disease Control and...

Active, not recruiting

Heterologous Boost Immunization With Ad5-nCoV After Three-dose Priming With an Inactivated SARS-CoV-2 Vaccine

COVID-19

China
The Second Affiliated Hospital of Chongqing Medical...

Recruiting

The Safety and Tolerability of MY-586 COVID-19 Neutralizing Antibody Nasal Spray in Healthy Subjects

SARS-CoV-2 | Prevention

China
Temple University
Dialysis Clinic, Inc.

Completed

DCI COVID-19 Surveillance Project

Covid19

United States
Alvogen Korea

Completed

Bioavailability Study of DP-R202 in Healthy Male Volunteers Under Fed Conditions

Healthy

Korea, Republic of
University of California, Irvine

Completed

A Prospective Study of a New Device for Monitoring Cerebral Oxygenation on Healthy Volunteers

Cerebral Ischemia

United States
Cinnagen
Vaxine Pty Ltd

Completed

Immunogenicity and Safety of the SpikoGen COVID-19 Vaccine in Children Aged 5 to <12 Years and 12 to <18 Years Compared With Adults Aged 18 to 40 Years

COVID-19

Iran, Islamic Republic of
Livzon Pharmaceutical Group Inc.

Completed

Recombinant SARS-CoV-2 Fusion Protein Vaccine (V-01) Booster Study (COVID-19)

COVID-19 Pandemic

Malaysia, Pakistan
Alvogen Korea

Completed

Safety and Pharmacokinetic Characteristics of DP-R202 in Healthy Male Volunteers

Healthy

Korea, Republic of
Institut National de la Santé Et de la Recherche...

Completed

Seroprevalence of IgG Antibodies to SARS-CoV-2 (COVID-19) in Primary Health Care Workers and Their Household Contacts (COVID-SeroPRIM)

Covid19

France
ACM Biolabs

Completed

Booster Dose Study to Assess the Safety and Immunogenicity of ACM-001 Administered Intramuscularly or Intranasally.

SARS-CoV-2 Infection

Australia
Sinovac Research and Development Co., Ltd.

Completed

Safety and Immunogenicity Study of Inactivated Vaccine for Prophylaxis of SARS CoV-2 Infection (COVID-19)

COVID-19

China
AIM Vaccine Co., Ltd.
First Affiliated Hospital Bengbu Medical College; Ningbo Rongan Biological...

Not yet recruiting

A Cohort Study of SARS-CoV-2 Variant (Omicron BA.5) mRNA Vaccine in Participants Aged 18 Years and Over in Chinese People

SARS-CoV-2
University of Melbourne
Southern Star Research Pty Ltd.

Completed

Safety and Immune Response of Adjuvanted SARS-CoV-2 (COVID-19) Beta Variant RBD Recombinant Protein (DoCo-Pro-RBD-1 + MF59®) and mRNA (MIPSCo-mRNA-RBD-1) Vaccines in Healthy Adults

SARS-CoV-2

Australia
Centre Hospitalier Intercommunal Creteil
Association Clinique Thérapeutique Infantile du val de Marne; GPIP; Francophone...

Withdrawn

Part 2 on the Study Prevalence of SARS -Cov2 Carriage in Asymptomatic and Mildly-symptomatic Children (COVILLE2) (WHO) (COVILLE2)

COVID19
AusDiagnostics Pty Ltd.

Not yet recruiting

Clinical Evaluation of SARS-COV-2 (COVID-19), Influenza and RSV 8-Well MT-PCR Panel for In Vitro Diagnostics

Respiratory Viral Infection
Laboratorio Avi-Mex, S.A. de C.V.
National Council of Science and Technology, Mexico; Instituto Nacional de Enfermedades...

Completed

Phase II Study of AVX/COVID-12 Vaccine in Subjects With Prior SARS-CoV-2 Immunity Evidence

SARS CoV 2 Infection

Mexico
University of Milano Bicocca

Completed

Frequency of COVID-19 Antibodies in Patients With Hereditary Hematological Diseases (ThalaCoV)

Covid19 | Thalassemia Major

Italy
Baebies, Inc.

Not yet recruiting

FINDER® Instrument and FINDER® FLU A/B, RSV, SARS-CoV-2 Test Clinical Evaluation Protocol

Influenza A | RSV Infection | SARS CoV 2 Infection | Influenza Type B

United States
Windsor-Essex Compassionate Care Community
Cairo University

Recruiting

The Effect of Intrawound Vancomycin Powder in Spine Surgery

Spine Disease

Egypt, Canada
Sinovac Life Sciences Co., Ltd.

Completed

Safety of an Inactivated SARS-CoV-2 Vaccine (CoronaVac) in Children and Adolescents

COVID-19

China
William Beaumont Hospitals

Completed

Screening to Prophylax Against Clostridium Difficile Infection - (StoP CDI)

Clostridium Difficile Infection

United States
Centre de Recherches et d'Etude sur la Pathologie...

Completed

COVID-19 and HIV Patients (COCOVIH)

Covid19

France
Becton, Dickinson and Company

Withdrawn

Capturing Infectious COVID-19 Asymptomatic Cases in Singapore

Covid19 | SARS CoV-2

Singapore
Agencia Costarricense de Investigaciones Biomedicas
Caja Costarricense de Seguro Social; Fundación INCIENSA (FUNIN); Ministerio de... and other collaborators

Unknown

Evaluation of the Immune Response to SARS-CoV-2 Among Patients With Covid-19 in Costa Rica (RESPIRA)

COVID-19
Herlev Hospital
Rigshospitalet, Denmark; Hvidovre University Hospital; University Hospital Bispebjerg... and other collaborators

Completed

COVID-19: Investigation of Transmission and Immunisation Among Hospital Staff

COVID

Denmark
Livzon Pharmaceutical Group Inc.

Active, not recruiting

The Immunogenicity and Safety of V-01-351/V-01D Bivalence Vaccine (Omicron)

COVID-19 Pandemic

China
AIM Vaccine Co., Ltd.
First Affiliated Hospital Bengbu Medical College; Ningbo Rongan Biological...

Active, not recruiting

A Preliminary Exploratory Cohort Study of SARS-CoV-2 Variant (Omicron BA.5) mRNA Vaccine in Participants Aged 18 Years and Over in China

SARS-CoV-2

China
Novavax

Completed

Phase 3 Boosting Study for the SARS-CoV-2 rS Variant Vaccines (COVID-19)

COVID-19 | SARS CoV 2 Infection

Australia
Sinovac Research and Development Co., Ltd.

Completed

Study of the Commercial Scale SARS-CoV-2 Vaccine Against the Pilot Scale Among Adults, and Bridging Study of the Immunogenicity in Elderly Against That in Adults

Covid19

China
Institute of Medical Biology, Chinese Academy of...
West China Second University Hospital; Yunnan Center for Disease Control and...

Completed

Safety and Immunogenicity Study of an Inactivated SARS-CoV-2 Vaccine for Preventing Against COVID-19 in People Aged ⩾60 Years

COVID-19

China
US Department of Veterans Affairs

Completed

Respiratory Dysregulation and Breathing Training in Anxious Outpatients

Anxiety

United States
Novavax

Not yet recruiting

Phase 3 Lot Consistency Study of COVID-19 and Influenza Combination Vaccine

COVID-19
National Institute for Medical Research, Tanzania
University of Kinshasa (UNIKIN), Congo, The Democratic Republic of the (... and other collaborators

Not yet recruiting

Evaluation of Molecular Point-of-care Xpert® Xpress SARS-CoV-2 Detection Implementation in Resource-limited Settings (EXPERT-CoV-2)

COVID-19
Universidad Peruana Cayetano Heredia
National University of San Marcos, Peru

Completed

Efficacy, Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccines (Vero Cell) to Prevent COVID-19 in Healthy Adult Population In Peru Healthy Adult Population In Peru (Covid-Peru)

COVID-19

Peru
Rigshospitalet, Denmark

Completed

COVID-19 Surveillance of Patients and Healthcare Workers in a Hospital Department

COVID-19

Denmark
Mayo Clinic

Completed

Feasibility of Rapid COVID-19 Testing in Disadvantaged Populations

Coronavirus Disease (COVID-19)

United States
Max O'Donnell
New York Blood Center; Amazon.com, Inc.

Completed

Plasma Therapy of COVID-19 in Severely Ill Patients

SARS-CoV-2 Infection

United States, Brazil
University Hospital, Basel, Switzerland

Completed

Amotosalen-Ultraviolet A Pathogen-Inactivated Convalescent Plasma in Addition to Best Supportive Care and Antiviral Therapy on Clinical Deterioration in Adults Presenting With Moderate to Severe COVID-19

Coronavirus Disease 2019 Infectious Disease (COVID-19 Infection)

Switzerland
Cuneyt M. Alper
National Institute on Deafness and Other Communication Disorders (NIDCD)

Completed

Trans-Middle-Ear Mucosal Gas Exchange Project 1, Specific Aim 1

Middle Ear Gas Exchange

United States
University of Erlangen-Nürnberg
Neurological Rehabilitation Center Quellenhof; ZTM Bad Kissingen

Completed

Validation of a Smartwatch in Persons With Multiple Sclerosis

Multiple Sclerosis

Germany
Central Hospital, Nancy, France

Completed

SaRS-Cov-2 Antibodies Following Exposure to Coronavirus Disease 2019 (COVID-19) and/or Vaccination in Nursing Homes

COVID-19 Infection

France
Andrew Eisenberger

Terminated

Convalescent Plasma for Early Treatment of COVID-19

COVID-19 | SARS-CoV 2

Brazil
University of Thessaly

Completed

SARS CoV-2 Infection and Inflammatory Biomarkers

COVID-19 | Inflammation

Greece
Baiya Phytopharm Co., Ltd.

Not yet recruiting

Evaluation of Safety, Tolerability, Reactogenicity, Immunogenicity of Baiya SARS-CoV-2 Vax 2 as a Booster for COVID-19

COVID-19 | COVID-19 Vaccine

Thailand

Search clinical trials for: ZR202a-CoV

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Togo

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations